TipRanks
Go Ultimate55% OFF

Quang X Pham Insider Profile

4 Followers

Quang X Pham, Chairman & CEO, Director, Ten Percent Owner at Cadrenal Therapeutics, Inc., holds 298.59K shares in Cadrenal Therapeutics, Inc. (Ticker: CVKD).

Quang X Pham's Trading History

CVKD
Cadrenal Therapeutics, Inc.
Jul 01, 2026Chairman & CEO, Director, Ten Percent OwnerUninformative Sell22.42K$292.62K
CVKD
Insider Shares: 298.59K (10.41%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jul 01, 2026Uninformative Sell$22.42K7,400$3.03―
Jun 26, 2026Uninformative Sell$33.92K11,156$3.04―
Jun 24, 2026Uninformative Sell$39.83K11,444$3.48―
Jun 18, 2026Uninformative Sell$13.11K4,126$3.17―
Jun 15, 2026Uninformative Sell$70.35K18,124$3.88―

You May Also Like

Quang X Pham insider profile FAQ

What is the percentage of profitable transactions made by Quang X Pham?
The percentage of profitable transactions made by Quang X Pham is 50%.
What is the average return per transaction made by Quang X Pham?
The average return per transaction made by Quang X Pham is 25.00%.
What stocks does Quang X Pham hold?
Quang X Pham holds: CVKD stocks.
What was Quang X Pham’s latest transaction?
Quang X Pham’s latest transaction was an Uninformative Sell of $22.42K.
What was Quang X Pham's most profitable transaction?
Quang X Pham’s most profitable transaction was an Informative Sell of CVKD stock on September 26, 2025. The return on the trade was 91.80%.
What is Quang X Pham's role in Cadrenal Therapeutics, Inc.?
Quang X Pham's role in Cadrenal Therapeutics, Inc. is Chairman & CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.